Sign up
Quantellect · Congress · Trade Detail
NYSE: ABTAbbott Laboratories
RepublicanHouse

Mike Kelly sold Abbott Laboratories (NYSE: ABT)

Mike Kelly (R-PA), a U.S. Representative, has disclosed 3 trades in Abbott Laboratories (ABT) since 2015, 1 purchase and 2 sales, worth an estimated $49K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: Mike Kelly sold $15,001 - $50,000 of Abbott Laboratories (NYSE: ABT) on February 3, 2015. Since that trade, ABT is up +185.82% against the S&P 500 up +337.23%, an outperformance of -151.41%.

Across these filings, Mike Kelly has been a net seller of ABT (a buy-to-sell ratio of 0.50). The most recent disclosed ABT transaction shown was dated December 8, 2017. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

ABT trades
3
Disclosed Vol
$49K
Buys
1
33%
Sells
2
67%
Buy / Sell
0.50
ratio
First → Last
2015–2017

Mike Kelly's ABT trades vs the price

ABT is up +185.82% since Mike Kelly sold on February 3, 2015, versus +337.23% for the S&P 500.

Performance since this trade

Price change since trade
+185.82%
S&P 500 change since trade
+337.23%
Outperformance vs S&P 500
-151.41%

All Mike Kelly ABT trades

TradedTypeSizeReturnEst. profit
December 8, 2017SELL$46.94+125.00%
April 13, 2016BUY$35.94+193.82%+$12K
February 3, 2015SELL$36.95+185.82%

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Mike Kelly & ABT trading FAQ

Is it legal for Mike Kelly to trade Abbott Laboratories (ABT) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Abbott Laboratories (ABT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Mike Kelly sell ABT?

Mike Kelly disclosed a sale of $15,001 - $50,000 of Abbott Laboratories (ABT) on February 3, 2015, according to public STOCK Act filings.

How has ABT performed since Mike Kelly's trade?

Since Mike Kelly sold ABT on February 3, 2015, the stock is up +185.82%, versus +337.23% for the S&P 500 over the same period, an outperformance of -151.41%.

How many times has Mike Kelly traded ABT?

Mike Kelly has disclosed 3 ABT trades since 2015 (1 purchase and 2 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional ABT trades?

Quantellect tracks every disclosed congressional trade in Abbott Laboratories (ABT) on the Abbott Laboratories congressional trading page, which aggregates filings across all members of Congress.

Mike Kelly's ABT tradesAll congressional filings for Abbott LaboratoriesMike Kelly's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.